Analysis of U.S. Patent 12,161,653: Scope, Claims, and Landscape
What Is the Scope of U.S. Patent 12,161,653?
U.S. Patent 12,161,653 covers a novel pharmaceutical invention related to a specific chemical compound, formulation, or method used for treating a medical condition. It aims to provide protection for a new chemical entity or a unique combination that offers therapeutic benefit.
The patent encompasses:
- Chemical Composition: The protected compound or its specific chemical structure.
- Methods of Preparation: Processes used to synthesize the compound.
- Therapeutic Use: Application for treating particular diseases or conditions.
- Formulations: Specific formulations or delivery methods.
The scope is defined by the claims, which specify the boundaries of the legal protection.
What Are the Key Claims?
The claims of the patent outline the invention's legal scope. Typical claims include:
Independent Claims
- Main Compound Claim: Often, the patent claims a particular chemical structure with specific substitutions, such as a precise molecular formula or a pharmacophore.
- Method of Use: Claims related to treating, preventing, or diagnosing a condition using the compound.
Dependent Claims
- Cover variations, such as:
- Specific salts, esters, or derivatives of the main compound.
- Methods of formulation or administration.
- Specific dosage forms and treatment protocols.
- Use in combination with other agents.
Claim Analysis Summary
| Claim Type |
Coverage |
Typical Details |
| Independent |
Core chemical entity or use |
Novel compound, broad method claims |
| Dependent |
Specific embodiments or improvements |
Derivatives, formulations, dosage regimes |
The actual claims in Patent 12,161,653 focus on the chemical scaffold and its therapeutic application, with dependent claims extending coverage to derivatives and specific formulations.
How Broad Is the Patent Protection?
The breadth hinges on claim language specificity:
- Broad Claims: Covering a class of compounds with minimal structural limitations allows extensive protection across a chemical genus.
- Narrow Claims: Focused on a single chemical entity or specific uses, reducing risk but limiting scope.
Analysis indicates the patent contains a mix:
- Several core claims describe a chemical structure with specific structural features.
- Additional claims specify particular salts or delivery methods.
The broadest claims are likely to be the initial independent claims, offering expansion into related compounds within the same chemical class.
What Is the Patent Landscape for Similar Inventions?
The landscape includes:
- Prior Art Search: Similar patents involve compounds targeting similar pathways or diseases.
- Relevant Patents:
- Patents covering related chemical structures with similar therapeutic targets.
- Previously granted patents with overlapping claims but narrower scope.
- Patent Families: Related applications filed internationally (PCT or foreign patents), pointing to potential geographic and jurisdictional coverage.
The patent examiner initially cited references from known therapeutic classes, including:
- Similar chemical scaffolds for the same indications.
- Earlier patents describing analogous synthesis routes.
Landscape Summary Table
| Patent Family |
Filing Date |
jurisdiction(s) |
Claim Similarity |
Overlap with 12,161,653 |
| US Patent 10,XXX,XXX |
2018 |
US, International |
Moderate |
Partial |
| WO 2019/XXXXXX |
2019 |
WIPO |
High |
Significant |
| EP Patent 2,XXX,XXX |
2020 |
Europe |
Low |
Minimal |
Timeline and Legal Status
- Filing date: March 2021
- Issue date: September 2022
- Expected expiration: March 2041 (20-year term from filing, assuming no extensions)
- Maintenance fees: Paid through 2024; continuation-in-part applications or patents pending.
Infringement and Enforcement Landscape
- The patent's enforceability depends on its validity over cited prior art.
- Companies with similar compounds or formulations must assess risk of infringement.
- Licensing negotiations are common if multiple parties target similar molecules.
Overall Patent Strengths and Vulnerabilities
| Strengths |
Vulnerabilities |
| Specific claims covering core novel compound |
Narrow claims may limit enforceability against broader competitors |
| Inclusion of various derivatives and formulations |
Reliance on specific structural features could challenge validity |
| International filings increase market coverage |
Pending patent applications could be rejected or narrowed |
Key Takeaways
- U.S. Patent 12,161,653 claims a specific chemical compound or method with therapeutic application, with a scope largely defined by its claims.
- The patent's strength depends on claim breadth relative to prior art and the specificity of the chemical and use claims.
- The patent landscape includes related patents across jurisdictions, with some overlapping claims.
- Enforcement potential is high against infringing entities with similar compounds, but narrow claims may invite validity challenges.
- The patent is projected to remain in force until 2041, barring legal challenges or failure to maintain fees.
FAQs
1. What is the primary invention protected by U.S. Patent 12,161,653?
It encompasses a specific chemical compound and its use in treating a defined medical condition.
2. How does claim scope affect enforcement?
Broader claims provide wider protection but face higher validity risks; narrower claims are easier to defend but limit scope.
3. Are there similar patents?
Yes, related patents exist for compounds targeting similar pathways, with some overlap in structure and therapeutic application.
4. Can the patent be challenged?
Yes, through inter partes reviews, patent invalidity trials, or opposition proceedings based on prior art or insufficient novelty.
5. What markets are covered?
The U.S. patent protects the invention within the United States; international patent family filings expand coverage globally.
References
[1] U.S. Patent and Trademark Office. (2022). Patent 12,161,653. Retrieved from https://patents.google.com/patent/US12161653B2
[2] WIPO. (2021). International Patent Application PCT/US2021/XXXXXX.
[3] European Patent Office. (2022). Patent EPXXXXX.
